Database of adverse events associated with drugs and drug combinations

被引:0
|
作者
Aleksandar Poleksic
Lei Xie
机构
[1] University of Northern Iowa,Department of Computer Science
[2] The City University of New York,Department of Computer Science, Hunter College
[3] The City University of New York,Ph.D. Program in Computer Science, Biochemistry and Biology, The Graduate Center
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA’s postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature.
引用
收藏
相关论文
共 50 条
  • [31] Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
    S S Egger
    S Meier
    C Leu
    S Christen
    A Gratwohl
    S Krähenbühl
    M Haschke
    Bone Marrow Transplantation, 2010, 45 : 1197 - 1203
  • [32] Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
    Egger, S. S.
    Meier, S.
    Leu, C.
    Christen, S.
    Gratwohl, A.
    Kraehenbuehl, S.
    Haschke, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 (07) : 1197 - 1203
  • [33] Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits
    Brinker, A
    Beitz, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) : 99 - 102
  • [34] Sex differences in text-mined possible adverse drug events associated with drugs for psychosis
    Sorup, Freja Karuna Hemmingsen
    Eriksson, Robert
    Westergaard, David
    Hallas, Jesper
    Brunak, Soren
    Ejdrup Andersen, Stig
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (05) : 532 - 539
  • [36] Adverse events associated with commonly used glaucoma drugs
    Vogel, R
    Strahlman, E
    Rittenhouse, KD
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1999, 39 (02) : 107 - 124
  • [37] Adverse events associated with home administration of parenteral drugs
    Katelaris, CH
    Cheong, EA
    Sisson, C
    Anderson, EA
    Byth, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S223 - S223
  • [38] Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report Database
    Okada, Akira
    Sera, Shoji
    Taguchi, Maho
    Yamada, Hiroaki
    Nagai, Naomi
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (08) : 1264 - 1269
  • [39] Prevalence of adverse drug combinations in a large post-mortem toxicology database
    Terhi Launiainen
    Erkki Vuori
    Ilkka Ojanperä
    International Journal of Legal Medicine, 2009, 123
  • [40] Prevalence of adverse drug combinations in a large post-mortem toxicology database
    Launiainen, Terhi
    Vuori, Erkki
    Ojanpera, Ilkka
    INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2009, 123 (02) : 109 - 115